Align Technology (ALGN) Stock Price, News & Analysis

Company Overview

Align Technology, Inc. (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability. Align’s iTero intraoral scanners capture high-resolution digital impressions, streamlining treatment planning and reducing the need for conventional molds. In 2019, Align further broadened its digital portfolio with the acquisition of exocad, augmenting its software capabilities for dental labs to design restorations, prosthetics and orthodontic appliances.

Today, Align Technology serves dental professionals in more than 100 countries through a combination of direct sales offices and distributor partnerships. The company maintains manufacturing facilities in the United States and other strategic locations to meet global demand and ensure product consistency. With ongoing investments in research and development, Align continues to enhance its clinical applications, expand digital workflows and introduce patient engagement tools aimed at improving outcomes and practice efficiency worldwide.

Key Stats

• Today's Range: $160.99 to $167.13
• 50-Day Range: $155.16 to $196.05
• 52-Week Range: $122.00 to $208.30
• Volume: 446,362 shs
• Average Volume: 1.15 million shs
• Market Capitalization: $11.55 billion
• P/E Ratio: 27.03
• Dividend Yield: N/A
• Price Target: $205.85
• Consensus Rating: Moderate Buy

Align Technology Stock Analysis - MarketRank™

Align Technology scored higher than 68% of companies evaluated by MarketBeat, and ranked 322nd out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 1 strong buy rating, 8 buy ratings, 5 hold ratings, and no sell ratings.

Upside Potential

Align Technology has a consensus price target of $205.85, representing about 25.7% upside from its current price of $163.82.

Amount of Analyst Coverage

Align Technology has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 10.02%

Earnings Growth

Earnings for Align Technology are expected to grow by 10.02% in the coming year, from $9.48 to $10.43 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Align Technology is 27.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.57.

Price to Earnings Ratio vs. Sector

The P/E ratio of Align Technology is 27.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.37.

Price to Earnings Growth Ratio

Align Technology has a PEG Ratio of 1.74. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Align Technology has a P/B Ratio of 2.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.92% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 6.36.

Change versus previous month

Short interest in Align Technology has recently increased by 15.35%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Align Technology does not currently pay a dividend.

Dividend Growth

Align Technology does not have a long track record of dividend growth.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.42

News Sentiment

Align Technology has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.78 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Align Technology this week, compared to 8 articles on an average week.

Search Interest

Only 2 people have searched for ALGN on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.

MarketBeat Follows

2 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Align Technology insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.75% of the stock of Align Technology is held by insiders.

Percentage Held by Institutions

88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 4/29/2026
• Today: 6/03/2026
• 46th Annual William Blair Growth Stock Conference: 6/03/2026
• Jefferies Global Healthcare Conference 2026: 6/04/2026
• Goldman Sachs 47th Annual Global Healthcare Conference 2026: 6/08/2026
• Next Earnings (Estimated): 7/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:ALGN
• CIK: 1097149
• Web: www.aligntech.com
• Phone: (602) 742-2000
• Fax: 408-470-1010
• Employees: 20,290
• Year Founded: 1997

Price Target and Rating

• Average Price Target for Align Technology: $205.85
• High Price Target: $240.00
• Low Price Target: $150.00
• Potential Upside/Downside: +27.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $5.96
• Trailing P/E Ratio: 27.10
• Forward P/E Ratio: 17.01
• P/E Growth: 1.74
• Net Income: $410.35 million
• Net Margins: 10.50%
• Pretax Margin: 14.50%
• Return on Equity: 15.82%
• Return on Assets: 10.17%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.39
• Quick Ratio: 1.28

Sales & Book Value

• Annual Sales: $4.03 billion
• Price / Sales: 2.86
• Cash Flow: $11.28 per share
• Price / Cash Flow: 14.30
• Book Value: $56.43 per share
• Price / Book: 2.86

Miscellaneous

• Outstanding Shares: 71,620,000
• Free Float: 71,081,000
• Market Cap: $11.55 billion
• Optionable: Optionable
• Beta: 1.67